对多个乳腺癌细胞系对抗雄激素反应的分析
Yuka Kuroiwa1,2, Kagenori Ito1,3, Jun Nakayama1
1Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
Genes to cells : devoted to molecular & cellular mechanisms
|February 17, 2024
概括
抗雄激素药物在乳腺癌细胞中表现出抗增殖作用,即使是缺乏雄激素受体 (AR) 信号的乳腺癌细胞. 生物标志物是必要的,以确定谁将从这些治疗中受益的患者.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对前列腺癌开发的抗雄激素正在被探索用于乳腺癌治疗.
- 由于实验模型有限,雄激素信号在乳腺癌中的作用仍然存在争议.
研究的目的:
- 综合调查抗雄激素在乳腺癌中的疗效.
- 为了确定雄激素受体 (AR) 状态和抗雄激素敏感性之间的关系.
主要方法:
- 用雄激素受体 (AR) 激动剂和抗剂治疗18种乳腺癌细胞系.
- 细胞增殖和AR变体表达的评估 (AR-V7,ARV567es).
- 对AR-knockout细胞系的抗雄激素作用的评估.
主要成果:
- 只有T-47D细胞表现出受素依赖的增殖;其他细胞在很大程度上没有反应.
- AR抗体抑制了T-47D细胞和一些AR低/负细胞中的增殖.
- 抗抗原表达水平和拼接变体与抗雄激素敏感性无关;影响可以独立于AR.
结论:
- 抗雄激素在乳腺癌中的有效性可能不仅仅取决于AR信号传递.
- 抗逆转基因抗生素对抗剂表现出独立于AR的抗增殖作用.
- 生物标志物识别对于患者选择抗雄激素治疗至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K